Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Takeda Pharmaceutical has the lowest figure of the 61 pharmaceutical companies ranked by short interest, at 0.10%, followed by AstraZeneca (0.20%) and Novartis (0.24%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Takeda Pharmaceutical0.10%
- Median
- 5.47%
- Combined market value
- ZAR 87.82T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Takeda PharmaceuticalTAK · Health Care | 0.10% | ZAR 1.18T | ZAR 369.11 | 1.29% down | 54% up | ||
| 2 | AstraZenecaAZN · Health Care | 0.20% | ZAR 4.81T | ZAR 3,099.25 | 1.60% down | 2% up | ||
| 3 | NovartisNVS · Health Care | 0.24% | ZAR 5.08T | ZAR 2,692.21 | 2.10% down | 25% up | ||
| 4 | SanofiSNY · Health Care | 0.51% | ZAR 1.96T | ZAR 816.68 | 0.57% down | 4% down | ||
| 5 | Johnson & JohnsonJNJ · Health Care | 0.71% | ZAR 11.43T | ZAR 4,748.33 | 1.41% down | 38% up | ||
| 6 | GSKGSK · Health Care | 0.81% | ZAR 1.69T | ZAR 842.16 | 1.03% down | 6% up | ||
| 7 | Eli LillyLLY · Health Care | 0.81% | ZAR 21.43T | ZAR 24,056.14 | 1.66% down | 35% up | ||
| 8 | Novo NordiskNVO · Health Care | 0.87% | ZAR 3.01T | ZAR 682.75 | 2.92% down | 17% down | ||
| 9 | GrifolsGRFS · Health Care | 0.88% | ZAR 99.4B | ZAR 146.02 | 2.09% down | 1% up | ||
| 10 | AbbVieABBV · Health Care | 0.89% | ZAR 8.77T | ZAR 4,959.06 | 2.00% down | 26% up | ||
| 11 | Merck & CoMRK · Health Care | 1.08% | ZAR 5.88T | ZAR 2,386.26 | 3.68% down | 51% up | ||
| 12 | Abbott LaboratoriesABT · Health Care | 1.10% | ZAR 3.13T | ZAR 1,805.98 | 0.19% down | 17% down | ||
| 13 | BeOne MedicinesONC · Health Care | 1.40% | ZAR 799.1B | ZAR 6,996.17 | 2.03% down | 17% up | ||
| 14 | GenmabGMAB · Health Care | 1.57% | ZAR 548.5B | ZAR 889.60 | 0.92% down | 70% up | ||
| 15 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | ZAR 2.36T | ZAR 9,311.24 | 0.87% up | 27% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | ZAR 1.69T | ZAR 16,384.82 | 1.00% down | 36% up | ||
| 17 | Royalty PharmaRPRX · Health Care | 2.27% | ZAR 689.7B | ZAR 1,199.44 | 1.06% up | 78% up | ||
| 18 | Bristol-Myers SquibbBMY · Health Care | 2.29% | ZAR 2.12T | ZAR 1,037.52 | 2.14% down | 34% up | ||
| 19 | PfizerPFE · Health Care | 2.36% | ZAR 2.77T | ZAR 486.27 | 1.16% down | 14% up | ||
| 20 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | ZAR 848.5B | ZAR 727.16 | 1.27% down | 74% up | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | ZAR 216.5B | ZAR 259.64 | 1.59% up | 5% up | ||
| 22 | ViatrisVTRS · Health Care | 3.07% | ZAR 410.3B | ZAR 357.88 | 1.27% up | 96% up | ||
| 23 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | ZAR 132.7B | ZAR 380.86 | 4.36% up | 83% up | ||
| 24 | Belite BioBLTE · Health Care | 3.40% | ZAR 110.7B | ZAR 2,725.13 | 0.01% down | 31% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | ZAR 348.2B | ZAR 2,599.59 | 3.88% down | 66% down | ||
| 26 | ZoetisZTS · Health Care | 4.12% | ZAR 598.6B | ZAR 1,473.16 | 2.12% up | 29% down | ||
| 27 | United TherapeuticsUTHR · Health Care | 4.31% | ZAR 428.2B | ZAR 10,055.16 | 0.38% down | 23% up | ||
| 28 | Ascendis PharmaASND · Health Care | 4.57% | ZAR 307B | ZAR 4,680.42 | 0.13% down | 28% up | ||
| 29 | ABIVAXABVX · Health Care | 4.70% | ZAR 126.8B | ZAR 1,448.88 | 2.13% up | 27% down | ||
| 30 | Summit TherapeuticsSMMT · Health Care | 5.28% | ZAR 145.6B | ZAR 182.05 | 1.27% down | 36% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | ZAR 129.2B | ZAR 1,644.24 | 0.04% up | 126% up | ||
| 32 | Legend BiotechLEGN · Health Care | 6.13% | ZAR 54.4B | ZAR 280.29 | 0.68% up | 42% down | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | 6.20% | ZAR 122.4B | ZAR 2,326.47 | 0.97% down | 7% down | ||
| 34 | Roivant SciencesROIV · Health Care | 6.28% | ZAR 482.7B | ZAR 666.16 | 0.41% down | 90% up | ||
| 35 | InsmedINSM · Health Care | 6.42% | ZAR 456.6B | ZAR 2,081.52 | 1.15% down | 40% down | ||
| 36 | Elanco Animal HealthELAN · Health Care | 6.59% | ZAR 232.3B | ZAR 464.67 | 4.02% up | 20% up | ||
| 37 | Definium TherapeuticsDFTX · Health Care | 7.02% | ZAR 68.2B | ZAR 497.85 | 1.94% down | 169% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | ZAR 203.1B | ZAR 1,048.75 | 3.73% up | 11% up | ||
| 39 | VeradermicsMANE · Health Care | 8.03% | ZAR 90.9B | ZAR 2,155.39 | 0.72% down | 233% up | ||
| 40 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | ZAR 106B | ZAR 749.54 | 0.90% up | 10% up | ||
| 41 | Corcept TherapeuticsCORT · Health Care | 8.34% | ZAR 128.7B | ZAR 1,175.85 | 2.89% down | 8% down | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | ZAR 273.9B | ZAR 4,266.98 | 2.58% up | 37% up | ||
| 43 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | ZAR 162.9B | ZAR 7,011.90 | 3.84% down | 24% down | ||
| 44 | PTC TherapeuticsPTCT · Health Care | 9.31% | ZAR 87.1B | ZAR 1,042.05 | 0.10% down | 20% down | ||
| 45 | Oruka TherapeuticsORKA · Health Care | 9.53% | ZAR 112.5B | ZAR 1,658.93 | 0.33% down | 241% up | ||
| 46 | Travere TherapeuticsTVTX · Health Care | 9.96% | ZAR 84.7B | ZAR 882.86 | 0.02% down | 44% up | ||
| 47 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | ZAR 104B | ZAR 1,592.40 | 0.22% up | 31% up | ||
| 48 | Cogent BiosciencesCOGT · Health Care | 10.0% | ZAR 84B | ZAR 482.90 | 0.34% up | 20% down | ||
| 49 | ErascaERAS · Health Care | 10.6% | ZAR 81.2B | ZAR 231.39 | 3.60% down | 403% up | ||
| 50 | BridgeBio PharmaBBIO · Health Care | 10.7% | ZAR 262.8B | ZAR 1,349.26 | 1.67% up | 17% up | ||
| 51 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | ZAR 78.8B | ZAR 719.90 | 0.90% down | 88% up | ||
| 52 | AlkermesALKS · Health Care | 11.7% | ZAR 136.1B | ZAR 810.19 | 3.16% up | 58% up | ||
| 53 | Spyre TherapeuticsSYRE · Health Care | 12.2% | ZAR 158.8B | ZAR 1,672.40 | 3.17% up | 286% up | ||
| 54 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | ZAR 104.4B | ZAR 5,217.06 | 2.76% up | 43% up | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | ZAR 80.5B | ZAR 483.16 | 3.71% up | 64% down | ||
| 56 | CytokineticsCYTK · Health Care | 12.9% | ZAR 123.8B | ZAR 888.56 | 0.45% down | 20% down | ||
| 57 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | ZAR 148.8B | ZAR 5,322.38 | 0.96% up | 61% up | ||
| 58 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | ZAR 142B | ZAR 2,175.05 | 0.96% up | 46% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | ZAR 84.7B | ZAR 1,504.52 | 0.10% up | 113% up | ||
| 60 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | ZAR 144.8B | ZAR 2,088.00 | 3.62% up | 13% up | ||
| 61 | TG TherapeuticsTGTX · Health Care | 19.0% | ZAR 172.6B | ZAR 1,142.24 | 5.41% up | 107% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2805 ZAR).
Questions and answers
Which pharmaceutical companies have the lowest short interest?
Takeda Pharmaceutical (0.10%), AstraZeneca (0.20%) and Novartis (0.24%) have the lowest short interest of the 61 pharmaceutical companies ranked here as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of ZAR 87.82T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.